Reference Interval:
0.0-3.5 ng/mL
|
| Interpretive Data: |
The Siemens Immulite® 2000 PAP chemiluminescent immunoassay method is used. Results obtained with different assay methods or kits cannot be used interchangeably. Measurement of PAP has been shown to be clinically relevant in the management of patients with prostatic adenocarcinoma. Benign prostatic hyperplasia, prostate massage, and prostatic infarction may result in elevated PAP concentrations. The PAP assay value, regardless of level, should not be interpreted as evidence for the presence or absence of malignant disease.
|
| CPT Code(s): |
84066
|
|